Cerebral Protection in Transcatheter Left Atrial Appendage Occlusion
Cerebral Protection in Transcatheter Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation
Silesian Centre for Heart Diseases
240 participants
May 26, 2023
INTERVENTIONAL
Conditions
Summary
The study aims to assess the effect of the use of neuroprotection in transcutaneous occlusion of the left atrial appendage in patients with atrial fibrillation on the risk of perioperative silent brain ischemia and associated cognitive impairment and depression.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
After aortography the cerebral protection system will be delivered to cerebral arteries through radial access before accessing the left atrium.
Only the aortography through radial access will be done before accessing the left atrium.
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05369195